MNTA - Momenta Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5958.5M
Enterprise Value 3669.31M
Trailing P/E N/A
Forward P/E 1-5.82
PEG Ratio (5 yr expected) 10.04
Price/Sales (ttm)12.81
Price/Book (mrq)2.20
Enterprise Value/Revenue 38.94
Enterprise Value/EBITDA 6-4.54

Trading Information

Stock Price History

Beta (3Y Monthly) 2.23
52-Week Change 3-68.52%
S&P500 52-Week Change 36.04%
52 Week High 332.20
52 Week Low 39.54
50-Day Moving Average 311.74
200-Day Moving Average 312.85

Share Statistics

Avg Vol (3 month) 3473.32k
Avg Vol (10 day) 3465.28k
Shares Outstanding 598.61M
Float 93.56M
% Held by Insiders 12.07%
% Held by Institutions 198.05%
Shares Short (Jun 28, 2019) 43.42M
Short Ratio (Jun 28, 2019) 46.41
Short % of Float (Jun 28, 2019) 45.78%
Short % of Shares Outstanding (Jun 28, 2019) 43.46%
Shares Short (prior month May 31, 2019) 43.57M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin -231.49%
Operating Margin (ttm)-217.21%

Management Effectiveness

Return on Assets (ttm)-20.83%
Return on Equity (ttm)-45.78%

Income Statement

Revenue (ttm)74.85M
Revenue Per Share (ttm)0.90
Quarterly Revenue Growth (yoy)-15.20%
Gross Profit (ttm)25.59M
EBITDA -147.44M
Net Income Avi to Common (ttm)-173.27M
Diluted EPS (ttm)-2.07
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)335.27M
Total Cash Per Share (mrq)3.53
Total Debt (mrq)91.5M
Total Debt/Equity (mrq)21.65
Current Ratio (mrq)6.71
Book Value Per Share (mrq)4.43

Cash Flow Statement

Operating Cash Flow (ttm)-155.03M
Levered Free Cash Flow (ttm)-60.61M